Literature DB >> 2305336

Vulvovaginal candidiasis complicating recurrent bacterial vaginosis.

V Redondo-Lopez1, C Meriwether, C Schmitt, M Opitz, R Cook, J D Sobel.   

Abstract

In this study the authors reveal a high incidence of asymptomatic and symptomatic vulvovaginal yeast infection in patients with recurrent bacterial vaginosis. Symptomatic yeast vaginitis in these patients presents frequently as a mixed infection with symptoms and signs of both clinical entities being present simultaneously. The authors diagnosed vulvovaginal candidiasis in 10 (29%) out of 35 patients with a history of recurrent bacterial vaginosis; vulvovaginal candidiasis and bacterial vaginosis together were detected in 12 (34%) out of 35 women. Optimal therapeutic results usually require concomitant treatment of both candidal vaginitis and bacterial vaginosis. The lack of specificity of signs and symptoms of vaginitis mandates that women with recurrent bacterial vaginosis, for each symptomatic recurrence, be examined and evaluated by the use of simple laboratory tests to determine a specific diagnosis. Failure to appreciate the frequency of candida superinfection leads to empirical and inappropriate therapy for bacterial vaginosis.

Entities:  

Mesh:

Year:  1990        PMID: 2305336

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

1.  Recurrent Bacterial Vaginosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

Review 2.  Bacterial vaginosis.

Authors:  C A Spiegel
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  Mixed vaginitis-more than coinfection and with therapeutic implications.

Authors:  Jack D Sobel; Chitra Subramanian; Betsy Foxman; Marilyn Fairfax; Scott E Gygax
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

4.  Characterization of a fish antimicrobial peptide: gene expression, subcellular localization, and spectrum of activity.

Authors:  A M Cole; R O Darouiche; D Legarda; N Connell; G Diamond
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

5.  An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.

Authors:  Paul L Fidel; Melissa Barousse; Terri Espinosa; Mercedes Ficarra; Joy Sturtevant; David H Martin; Alison J Quayle; Kathleen Dunlap
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

6.  Bacterial vaginosis and the natural history of human papillomavirus.

Authors:  Caroline C King; Denise J Jamieson; Jeffrey Wiener; Susan Cu-Uvin; Robert S Klein; Anne M Rompalo; Keerti V Shah; Jack D Sobel
Journal:  Infect Dis Obstet Gynecol       Date:  2011-08-16

7.  Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota.

Authors:  Stephanie L Collins; Amy McMillan; Shannon Seney; Charlotte van der Veer; Remco Kort; Mark W Sumarah; Gregor Reid
Journal:  Appl Environ Microbiol       Date:  2018-02-14       Impact factor: 4.792

8.  Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in India.

Authors:  Sujit D Rathod; Jeffrey D Klausner; Karl Krupp; Arthur L Reingold; Purnima Madhivanan
Journal:  Infect Dis Obstet Gynecol       Date:  2012-10-15

9.  Bacterial vaginosis and trichomoniasis: epidemiology and management of recurrent disease.

Authors:  D E Soper
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.